INFORMACIÓN ACADÉMICA Y ADMISIONES
Credits - 30 / European ECTS credits
Pre-selection process: Open
Inscriptions Open: from June 2019 to January 2020
Postgraduate Program – from the 3rd of February 2019 to the 28th of May 2019.
Full Time - Monday to Thursday from 18:00h. to 21:00h.
Language - English
OBJETIVOS DEL POSTGRADO
The objective of the program is to acquire a specialized knowledge in corporate finance and corporate law in late stage negotiation agreements between pharma and biotech in portfolio management. The main skills and topics are related with international negotiation processes in licensing agreements or merge and acquisitions, corporate finance and corporate law for the deal head establishment, upfront and milestones.
The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers.
TITULACIÓN DEL POSTGRADO
Los estudiantes que aprueben el programa recibirán una doble titulación de la Universidad de Barcelona y del Instituto Empresarial de Biotecnologia en Postgrado de Especialización en Licencias y Gestión de Portfolios.